This document outlines an RNA-Seq differential expression analysis workflow to identify differentially expressed genes between breast tumor and normal tissue samples. The proposed pipeline includes quality control checks, mapping reads to the human genome, counting reads per gene, normalization methods to account for sequencing depth differences, and four statistical analysis methods (DESeq, DESeq2, edgeR, voom-Limma) to identify differentially expressed genes while controlling the false discovery rate. Visualization of sample distances and principal components analysis are used for quality control. The results are compared across methods to determine overlapping significant genes. Further biological insights from these gene lists are suggested.